Google’s Isomorphic Labs to raise over $2 billion in new funding

Short summary

Isomorphic Labs, Alphabet's AI drug discovery subsidiary, is securing over $2 billion in new funding led by Thrive Capital. The investment will accelerate its drug design engine development and fund aggressive global expansion. The deal reflects Alphabet's strategy to commercialize advanced AI capabilities in the pharmaceutical and healthcare sectors.

• •Isomorphic Labs raising $2B+ led by Thrive Capital
• •Capital targets drug design engine acceleration and international growth
• •Reflects Alphabet's commercial push for enterprise AI in regulated industries

Generated with AI, which can make mistakes.